Products Affected - Description

• • Wegovy 0.25 mg dose subcutaneous solution for injection, Novo Nordisk, 0.25 mg/0.5 mL, pen injector, 4 count, NDC 00169-4525-14
  • Wegovy 0.5 mg dose subcutaneous solution for injection, Novo Nordisk, 0.5 mg/0.5 mL, pen injector, 4 count, NDC 00169-4505-14
  • Wegovy 1 mg dose subcutaneous solution for injection, Novo Nordisk, 1 mg/0.5 mL, pen injector, 4 count, NDC 00169-4501-14

Reason for the Shortage

• • Novo Nordisk has Ozempic on shortage due to increased demand. Novo Nordisk has discontinued Ozempic 0.25 mg and 0.5 mg dose strength in the 2 mg/1.5 mL presentation.
  • Novo Nordisk has Wegovy on shortage due to increased demand. The company has taken measures to increase production capacity; however, the supply is not anticipated to meet patient demand for the 0.25 mg, 0.5 mg, and 1 mg dose strengths. Additional product supply information can be found at https://www.novonordisk-us.com/products/product-supply-update.html

Available Products

• • Ozempic 0.25 mg or 0.5 mg doses subcutaneous solution for injection, Novo Nordisk, 2 mg/1.5 mL, pen injector, NDC 00169-4132-12 - discontinued
  • Ozempic 0.25 mg or 0.5 mg doses subcutaneous solution for injection, Novo Nordisk, 2 mg/3 mL, pen injector, NDC 00169-4181-13
  • Ozempic 1 mg doses subcutaneous solution for injection, Novo Nordisk, 4 mg/3 mL, pen injector, NDC 00169-4130-13
  • Ozempic 2 mg doses subcutaneous solution for injection, Novo Nordisk, 8 mg/3 mL, pen injector, NDC 00169-4772-12
  • Wegovy 1.7 mg dose subcutaneous solution for injection, Novo Nordisk, 1.7 mg/0.75 mL, pen injector, 4 count, NDC 00169-4517-14
  • Wegovy 2.4 mg dose subcutaneous solution for injection, Novo Nordisk, 2.4 mg/0.75 mL, pen injector, 4 count, NDC 00169-4524-14

• • Novo Nordisk has Wegovy 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, and 1 mg/ 0.5 mL prefilled pens on allocation.